|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| C07D 487/04 | |||
| A61K 31/395 | |||
| A61P 17/00 | |||
| A61P 35/00 | |||
| A61P 37/00 |
| (11) | Number of the document | 2343298 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11152674.5 |
| Date of filing the European patent application | 2006-12-12 | |
| (97) | Date of publication of the European application | 2011-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 749905 P | 2005-12-13 | US | |
| 810231 P | 2006-06-02 | US | |
| 850625 P | 2006-10-10 | US | |
| 856872 P | 2006-11-03 | US | |
| 859404 P | 2006-11-16 | US |
| (72) |
Rodgers, James D., US
Shepard, Stacey, US
Maduskuie, Thomas P., US
Wang, Haisheng, US
Falahatpisheh, Nikoo, US
Rafalski, Maria, US
Arvanitis, Argyrios G., US
Storace, Louis, US
Jalluri, Ravi Kumar, US
Fridman, Jordan S., US
Vaddi, Krishna, US
|
| (73) |
Incyte Corporation,
1801 Augustine Cut-Off, Wilmington, DE 19803,
US
|
| (54) | Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |